Do structurally similar molecules have similar biological activity?

被引:611
作者
Martin, YC [1 ]
Kofron, JL
Traphagen, LM
机构
[1] Abbott Labs, Global Pharmaceut Res & Dev, Comp Assisted Mol Design Dept R47E, Abbott Pk, IL 60064 USA
[2] Abbott Labs, Global Pharmaceut Res & Dev, Dept Biomol Screening R4PN, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm020155c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To design diverse combinatorial libraries or to select diverse compounds to augment a screening collection, computational chemists frequently reject compounds that are greater than or equal to0.85 similar to one already chosen for the combinatorial library or in the screening set. Using Daylight fingerprints, this report shows that for IC50 values determined as a follow-up to 115 high-throughput screening assays, there is only a 30% chance that a compound that is greater than or equal to 0.85 (Tanimoto) similar to an active is itself active. Although this enrichment is greater than that found with random screening and docking to three-dimensional structures, this low fraction of actives within similar compounds occurs not only because of deficiencies in the Daylight fingerprints and Tanimoto similarity calculations but also because similar compounds do not necessarily interact with the target macromolecule in similar ways. The current study emphasizes the statistical or probabilistic nature of library design and that perfect results cannot be expected.
引用
收藏
页码:4350 / 4358
页数:9
相关论文
共 48 条